Comparison Overview
Eurofins Clinical Trial Solutions

Eurofins Clinical Trial Solutions
N/A
Last Update: 20/03/2026
Complex innovative clinical trial designs require an integrated synergetic approach to assess novel drug compounds for safety and effectiveness which often span esoteric, regulated and safety outcomes in all phases of the drug development life cycle. The companies of Eu...

Amgen
One Amgen Center Drive, Thousand Oaks, CA, US, 91320
Last Update: 14/06/2026
Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human gene...
Compliance Ranges Comparison

Eurofins Clinical Trial Solutions







Amgen






Benchmark & Cyber Underwriting Signals
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Eurofins Clinical Trial Solutions in 2026.
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Amgen in 2026.
Incident History - Eurofins Clinical Trial Solutions (X = Date, Y = Severity)
Eurofins Clinical Trial Solutions cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Amgen (X = Date, Y = Severity)
Amgen cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

Eurofins Clinical Trial Solutions

Amgen
FAQ
Latest Global CVEs
Improper access control in Microsoft Edge for Android allows an unauthorized attacker to bypass a security feature over a network.
A security vulnerability has been detected in NousResearch hermes-agent up to 2026.4.30. Affected is the function GatewayStreamConsumer._filter_and_accumulate of the file gateway/stream_consumer.py of the component Streaming Reasoning Tag Filter. The manipulation leads to improper handling of case sensitivity. The attack may be initiated remotely. The attack's complexity is rated as high. The exploitability is told to be difficult. The exploit has been disclosed publicly and may be used. The project decided to not implement a dedicated fix: "[T]he analysis and the fix are both sound. It just lands below the bar for the maintenance cost of a duplicated scrub path."
- https://gist.github.com/YLChen-007/2229e5505bcbb3e15a7ae8fba4c4be37
- https://github.com/NousResearch/hermes-agent/
- https://github.com/NousResearch/hermes-agent/issues/27288
- https://github.com/NousResearch/hermes-agent/pull/28631#issuecomment-4622188016
- https://vuldb.com/cve/CVE-2026-14617
- https://vuldb.com/submit/844654
- https://vuldb.com/vuln/376134
- https://vuldb.com/vuln/376134/cti
Insufficient ui warning of dangerous operations in Microsoft Edge (Chromium-based) allows an unauthorized attacker to perform spoofing over a network.
Improper neutralization of input during web page generation ('cross-site scripting') in Microsoft Edge (Chromium-based) allows an unauthorized attacker to perform spoofing over a network.
Relative path traversal in Microsoft Edge for Android allows an unauthorized attacker to disclose information locally.